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Abstract
A simple, specific and accurate reverse phase high performance liquid chromatographic method was 
developed for simultaneous estimation of Cefixime and Dicloxacillin in bulk drug and tablet dosage form.  
Sepration was achieved by capcell pack C-18 column having 250 mm× 4.6 mm i.d. in isocratic mode, with 
mobile phase containing 0.05 M potassium dihydrogen phosphate: methanol (25:75), adjusted to pH 4.5 using 
ortho phosphoric acid. The flow rate was 1.0 ml/min and effluents were monitored at 232 nm. The retention 
time of Cefixime and Dicloxacillin were 3.19 min and 6.68 min respectively. The linearity for Cefixime and  
Dicloxacillin were in the range of 10-100 µg/ml. The recoveries of Cefixime and Dicloxacillin were found in 
the range of 99.63-99.95 % and 99.58-99.98 % respectively. The proposed method was validated as per ICH 
and USP guidelines and successfully applied to the estimation of Cefixime and Dicloxacillin in bulk drug and 
tablet dosage form.
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1. Introduction
Analytical  chemistry is  the  analysis of 
material  samples  to  gain  an  understanding  of  their 
chemical  composition and  structure. Analytical 
chemistry  is  the  science  of  making  quantitative 
measurements. In practice,  quantifying analytes in a 
complex  sample  becomes  an  exercise  in  problem 
solving.  To  be  effective  and  efficient,  analyzing 
samples requires expertise in the chemistry that can 
occur  in  a  sample  analysis  and  sample  handling 
methods for a wide variety of problems (the tools-of-
the-trade) proper data analysis and record keeping.1,2 
Analytical  chemistry  requires  broad  background 
knowledge of chemical and physical concepts. These 
hypermedia  documents  contain  links  to  the 
fundamental  principles  that  underly  the  different 
analytical  methods.  With  a  fundamental 
understanding of analytical methods, a scientist faced 
with a difficult analytical problem can apply the most 
appropriate  technique(s).  A  fundamental 
understanding also makes it easier to identify when a 
particular  problem  cannot  be  solved  by  traditional 
methods and gives an analyst  the knowledge that is 
needed  to  develop  creative  approaches  or  new 
analytical methods.3 Analytical chemistry is the study 
of the chemical composition of natural and artificial 
materials.  Properties  studied  in  analytical  chemistry 
include  geometric  features  such  as  molecular 
morphologies and distributions of species, as well as 
features  such  as  composition  and  species  identity. 
Unlike  the  sub  disciplines  inorganic  chemistry  and 
organic chemistry, analytical chemistry (like physical 
chemistry)  is not restricted to any particular type of 
chemical  compound  or  reaction.  The  contributions 
made by analytical chemists have played critical roles 
in  the  sciences  ranging  from  the  development  of 
concepts and theories (pure science)  to a variety of 
practical  applications,  such  as  biomedical 
applications,  environmental  monitoring,  quality 
control  of  industrial  manufacturing  and  forensic 
science (applied science).4
2. Materials and Instruments
Drug sample suppliers & Manufacturers:
Table 1: Drug sample suppliers & Manufacturers:
S.No Name of 
Drugs
Drug supplies & 
Manufacturers.
1 Cefixime Emcure Pharmaceutical Ltd. 
Pune
2 Dicloxacillin Aurobindo Pharma Ltd. 
Hydrabad
List of Reagents and Chemicals used:
Table 2: List of Reagents and Chemicals used:
Name of chemicals Suppliers
Ortho- phosphoric acid Research  Lab  Fine  Chem. 
Industries
Methanol AR grade Merk Ltd., Mumbai
Glacial actic acid HPLC 
grade
Research  Lab  Fine  Chem 
Industries, Mumbai.
Acetonitrile HPLC grade Merk  Specialities  Pvt.  Ltd., 
Mumbai
Methanol HPLC grade Thomas  Baker  (chemicals) 
Pvt. Ltd., Mumbai
Instrument used:
Table 3: Instrument used:
Equipments Company
AUX220 electronic balance Shimadzu 
corporation, Japan
V-530 UV-Visible double beam 
spectrophotometer
JASCO 
corporation, Japan
Cyberlab HPLC system 2003
LC-P-100  HPLC pump
Rheodyne manual sample injector
Capcell pack C-18 
(4.6mm×250mm) column 
LC-UV-100 as UV-VIS detector
Cyberlab 
corporation, Japan
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 Softwares used:  Shanupro.
2.1 Methodology
2.1. 1. Determination of λmax of Cefixime:
Fig.1: UV spectra of Cefixime
 The  standard  solution  of  Cefixime  was 
scanned  at  different  concentrations  in  the  range  of 
200-400 nm and the λmax was  found to  be  290 nm 
against reagent blank.
2.1.2. Determination of λ max of Dicloxacillin:
          Fig. 2: UV spectra of Dicloxacillin
The standard solution of Dicloxacillin was scanned at 
different concentrations in the range of 200-400 nm 
and the λ max was found to be 210 nm against reagent 
blank
2.2  RP-HPLC  Method  for   Cefixime  and 
Dicloxacillin.
Determination of Cefixime and Dicloxacillin 
in combined tablet dosage form. 
Method 1. Solubility of drugs in different solvents:
Solubility  of  both  drugs  was  observed  by 
dissolving them in different solvents.
Table. 4:  Solubility of drugs in different solvents:
Solvents Solubility
Cefixime         Dicloxacillin
 ACN        +             +
 Water        +             +
Methanol        ++             ++
 (+++)  Symbolizes highly soluble,  (++) Symbolizes 
freely soluble, (+) Symbolizes soluble, (-) Symbolize 
insoluble.
Method 2: 
A. Selection of analytical wavelength:
By  appropiate  dilution  of  each  standard 
stock  solution  with  mobile  phase,  various 
concentrations  of  Cefixime  and  Dicloxacillin  were 
prepared  separately  .Each  solution  was  scanned  in 
between  the  range  of  200  nm to400  nm  and  their 
spectra  were  overlaid.  The  wavelength  selected  for 
the analysis was 232 nm which both the drugs showed 
significant  absorbance.  The overlain  UV spectra  of 
Cefixime and Dicloxacillin in the mobile phase are as 
shown in figure below. 
Fig. 3: Overlain spectra of Cefixime and 
Dicloxacillin
B. Calibration of Cefixime & Dicloxacillin:
 Take  10  mg  of  Cefixime  &  10  mg  of 
Dicloxacillin seperately in 100 mL volumetric flask 
which was then dissolved in 50 mL mobile phase with 
shaking. Then it was sonicated and the volume was 
made up to 100 mL. Suitable dilutions are made from 
the  standard  stock  solutions.  The  linearity  of  the 
relationship between peak area and concentration was 
determined by analyzing six working standards over 
the  concentration  range  of  10,  20,  30,  40,  50  and 
100μg/mL for  Cefixime  & 10,  20,  30,  40,  50  and 
100μg/mL  for  Dicloxacillin.  Hence  the  peak  areas 
were  recorded  against  concentration  &  graph  of 
concentration Vs peak area was plotted.  
Fig. 4: Chromatogram of 10 µg/mL of 
Cefixime
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Fig. 5: Chromatogram of 20 µg/mL of Cefixime
Fig. 6: Chromatogram of 30 µg/mL of Cefixime
Fig. 7: Chromatogram of 40 µg/mL of Cefixime
Fig. 8: Chromatogram of 50 µg/mL of Cefixime
                          
   Fig. 9: Chromatogram of 100 µg/mL of cefixime
 
 
Fig. 10: Calibration curve of Cefixime
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Fig. 11: Chromatogram of 10 µg/mL of 
Dicloxacillin
Fig. 12: Chromatogram of 20 µg/mL of 
Dicloxacillin
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Fig. 13: Chromatogram of 30 µg/mL of 
Dicloxacillin
Fig. 14: Chromatogram of 40 µg/mL of 
Dicloxacillin
Fig. 15: Chromatogram of 50 µg/mL of 
Dicloxacillin
 
Fig. 16: Chromatogram of 100 µg/mL of 
Dicloxacillin 
Fig. 17: Calibration curve of Dicloxacillin 
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Table. 5 : Calibration of Cefixime and 
Dicloxacillin
S.No
.
Conc. (μg/mL) Area (μV. sec)
Cefixime Dicloxacillin Cefixime Dicloxacillin
1 10 10 94574.0 92845.7
2 20 20 192020.4 181902.1
3 30 30 291273.8 268036.1
4 40 40 378547.9 354648.6
5 50 50 475633.9 426203.4
6 100 100 945467.8 844311.8
C. Selection of  mobile system:   The pure  drug of 
Cefixime and Dicloxacillin were injected into HPLC 
system by using different solvent systems. Different 
mobile  phases  like  aetonitrile:  methanol:  water, 
acetonitrile:  methanol:  potassium  dihydrogen 
phosphate  buffer,  methanol:  potassium  dihydrogen 
phosphate  buffer,  were  tried  in  order  to  find  the 
optimum conditions  for  the  seperation  of  Cefixime 
and Dicloxacillin.  Finally the optimum composition 
of the mobile phase was selected as methanol (75mL) 
mixed with 0.05M phosphate buffer (25mL), whose 
pH  was  adjusted  to  4.5  by  ortho-  phosphoric  acid 
which  gave  satisfactory  results  with  sharp  well 
defined and well resolved peaks and acceptable peak 
parameters as compared to other mobile phases.
D. Preparation of mobile phase:  Methanol (75mL) 
was mixed with 0.05M phosphate buffer (25 mL), and 
then  pH was  adjusted  to  4.5  by  addition  of  ortho-
phosphoric acid.
E. Degassing the mobile phase:  The mobile phase 
prepared was degassed by ultrasonication for about 20 
min,  so  as  to  avoid  the  disturbances  caused  by 
dissolved gases.
F.  Filtration  of  mobile  phase:  The  mobile  phase 
after  degassing  was  filtered  through  0.45  μm 
membrane nylon filter to remove the smaller particles 
that may be present in the mobile phase & which may 
cause clogging of column.
G. Preparation of standard stock solutions: 10 mg 
of Cefixime and 10 mg of Dicloxacillin were weighed 
seperately  and  dissolved  in  50ml  of  mobile  phase 
with shaking. Then it was sonicated and the volume 
was made upto 100 mL by using mobile phase. From 
standard stock solution of drug, appropriate dilutions 
were made using the mobile phase & the sample was 
filtered through 0.2 μm of clear filtrate were injected 
into the HPLC column.
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H. Loading of  mobile  phase: Filtered  & degassed 
mobile  phase  was  loaded  in  the  reservoir.  Priming 
was done for each freshly prepared mobile phase.
I. Baseline stabilization: The detector was turned on 
for an hour before the actual run in order to obtain the 
stable UV light.  The mobile phase run was started at 
desired flow rate and the run was continued until the 
stable baseline was obtained.
J.  Loading  of  samples:  Well  prepared  &  filtered 
samples  of  Cefixime and Dicloxacillin  were  loaded 
into the Rheodyne injector port using a syringe and 
the sample was then injected.
K.  Washing  the  column:  Once  the  analysis  of 
samples was finished, the column was first washed by 
flushing  with  the  mobile  phase  for  half  an  hour, 
afterwards with double distilled water & methanol in 
1:1 proportion for another one hour.
L.  Selection  &  Optimization  of  HPLC  method: 
After  the selection of  suitable mobile  phase,  it  was 
then optimized for its reproducibility, sensitivity and 
accuracy.
M.  Chromatogram  of  working  standard  for 
Cefixime and Dicloxacillin
Fig. 18: Chromatogram of working standard of  20 
µg/ml of cefixime
Fig. 19: Chromatogram of working standard 
50µg/ml of Dicloxacillin
 
Fig. 20: Chromatogram of working standard of 
20µg/ml of Cefixime and 
50µg/ml of Dicloxacillin                 
            Table. 6 : Details of chromatogram of working standard containing Cefixime and Dicloxacillin.
Sr. No Name RT (min) Area (μV.sec) Theoritical   plates Resolution Asymmetry
1 Cefixime 3.194 184282.7 2450.41 2.51 1.45
2 Dicloxacillin 6.683 417470.4 3470.89 2.42 1.26
N. Analysis of Tablet formulation:
Brand: HIFEN-LXX 200
Each Tablet contains:
Cefixime 200mg
Dicloxacillin 500 mg
Procedure: Take twenty tablets, each containing 200 
mg of Cefixime and Dicloxacillin 500 mg .The tablets 
were crushed to fine powder and amount of powder 
equivalent   100  mg  of  Cefixime  and   250  mg 
Dicloxacillin  were weighed and transferred to100 mL 
dried volumetric  flask.  Sufficient  amount of mobile 
phase was added to dissolve the content and shaken 
for 20 min. The volume was made up to 100 mL with 
mobile  phase.  Then  solution  was  filtered  by  using 
membrane  filter  and  digassed.  From  this  solution 
appropriate  dilutions  of  Cefixime  and  Dicloxacillin 
were made to get the final concentrations and injected 
into  the  system  to  get  the  chromatogram.  The 
chromatogram obtained is shown in fig no.20 and the 
area obtained in each chromatogram of five replicate 
was  correlated  with  regression  equation  and  the 
amount found is calculated which was within the limit 
of label claim as mentioned in table no.11.
Fig. 21: Chromatogram of Cefixime (20 μg/mL) & 
Dicloxacillin (50 μg/mL tablet) in Tablet 
Formulation.
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Table. 7: Details of chromatogram of Cefixime and Dicloxacillin.
Sr. No Name RT 
(min)
Area (μV sec) Therotical 
plates
Resolution Asymmetry
1 Cefixime 3.191 191454.5 2173.41 2.64 1.39
2 Dicloxacillin 6.684 423811.4 3430.89 2.42 1.93
Table 8: Analysis of HIFEN-LXX 200 Tablet.
Sr. no. Amount present in(µg) Amount found in(µg) % Label claimCefixime Dicloxacillin Cefixime Dicloxacillin Cefixime Diclo
1 20 50 19.94 49.75 99.73 99.50
2 20 50 19.94 49.67 99.71 99.35
3 20 50 19.96 49.60 99.81 99.20
4 20 50 19.91 49.73 99.59 99.47
5 20 50 19.89 49.86 99.47 99.73
O.  Evaluation  of  analytical  method  (Method 
validation):
 Linearity and sensitivity:
 Suitable  dilutions  of  different  concentrations 
using  mobile  phase  were  made  from  the  standard 
stock  solutions.  The  linearity  of  the  relationship 
between peak area and concentration was determined 
by  analyzing  six  working  standards  over  the 
concentration range 10-100 μg/ml for  Cefixime and 
10-100 μg/ml for Dicloxacillin. Here the peak areas 
were  recorded  against  concentration  &  graph  of 
concentration  Vs  peak  area  was  plotted.  Results 
obtained are shown in table below.  
Table. 9 : Linearity of Cefixime. (n=3)
Standard conc. 10 μg/mL 20 μg/mL 30 μg/mL 40 μg/mL 50 μg/mL 100 μg/mL
Replicates Peak area
1 94574 192020.4 291273.8 378547.9 475633.9 945467.8
2 93966.1 192256.1 291611.4 378810.1 475841.2 945211.7
3 94914.6 192411.7 291426.4 378947.4 476022.1 945569.4
Mean 94484.9 192229.4 291437.2 378768.5 475832.4 945416.3
± SD 480.48 197.01 169.05 202.97 194.24 184.32
%RSD 0.5085 0.1024 0.0580 0.0535 0.040 0.0194
Fig. 22: Calibration plot of Cefixime
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Table.10: Linearity Dicloxacillin. (n=3)
Standard conc. 10μg/mL 20μg/mL 30μg/mL 40μg/mL 50μg/mL 100μg/mL
Replicates Peak area
1 92845.7 181902.1 268036.1 354648.6 426203.4 844311.8
2 92805.1 181714.4 268214.3 354821.1 426501.4 844621.1
3 92817.4 181874.2 268411.8 354919.1 426412.6 844974.9
Mean 92822.7 181830.2 268220.7 354796.3 426372.5 844635.9
± SD 20.818 101.27 187.93 136.94 153.0 331.79
% RSD 0.0224 0.0556 0.070 0.0385 0.035 0.039
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Fig. 23: Calibration of Dicloxacillin
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Precision:  Repeatability  of  method  was  established  by  analyzing  various  replicates  standards  of  Cefixime  and 
Dicloxacillin. All the solutions were analyzed thrice, in order to record any intra-day & inter-day variation in the result.  
The result obtained for intraday variations are shown in table no.11, 12. & the result obtained for inter-day variations are  
shown in the table no.13, 14.                             
Table. 11: Intra-day variability of Cefixime
Conc.
(μg/mL)
Peak area (μV. sec) Mean area (μV 
sec) ± SD %RSDTrial 1 Trial 2 Trial 3
20 192020.4 191841.2 191928.4 191930.0 89.61 0.0466
30 291273.8 291411.7 291574.6 291420.0 150.57 0.051
40 378547.9 378634.2 378859.1 378680.4 160.66 0.0424
Table. 12: Intra-day variability of Dicloxacillin
Conc.
(μg/mL)
Peak area (μV. sec) Mean area (μV 
sec) ± SD % RSDTrial 1 Trial 2 Trial 3
20 181902.1 181711.2 181633.4 181748.9 138.26 0.076
30 268036.1 268224.2 268474.5 268244.9 219.93 0.081
40 354648.6 354801.7 354919.7 354790.0 135.92 0.0383
Table. 13: Inter-day variability of Cefixime
Conc.
(μg/mL)
Peak area (μV. sec) Mean area (μV. 
sec) ± SD %RSDDay 1 Day 2 Day 3
20 192414.4 192636.6 192811.4 192620.8 198.97 0.1032
30 291414.8 291605.1 291547.1 291522.3 97.53 0.0334
40 378878.1 378901.4 378793.4 378857.6 56.83 0.0150
Table. 14: Inter-day variability of Dicloxacillin.
Conc.
(μg/mL)
Peak area (μV. sec) Mean area 
(μV sec) ± SD %RSDDay 1 Day 2 Day 3
20 182011.4 182244.8 182334.1 182196.8 166.62 0.0914
30 268211.5 268347.5 268474.1 268344.4 131.32 0.0489
40 354648.6 354841.4 354939.2 354809.7 147.86 0.0416
Accuracy:  To  check  the  accuracy  of  proposed  method,  level  of  recovery  carried  out  at  80,  100  and  120% of  the 
concentration as per standard addition method. Here the product was accessed by addition of series of known amount of 
standard drug in the product and then the contents were estimated by assay method .The % recovery for Cefixime &  
Dicloxacillin is in the range. Results are shown in table no.15.
Table.15: Recovery studies of Cefixime and Dicloxacillin.
Tablet 
sample
Level of 
recovery
%
Amount  taken 
(μg/mL)
Amount of 
standard added 
(μg/ml)
Total amount 
recovered (μg/mL) %Recovery
Drug CEF DICLO CEF DICLO CEF DICLO CEF DICLO
80 20 50 16 40 35.90 89.89 99.72 99.87
80 20 50 16 40 35.87 89.99 99.63 99.98
80 20 50 16 40 35.91 89.94 99.75 99.93
100 20 50 20 50 39.97 99.64 99.92 99.64
100 20 50 20 50 39.96 99.72 99.90 99.72
100 20 50 20 50 39.93 99.58 99.82 99.58
120 20 50 24 60 43.98 109.76 99.95 99.78
120 20 50 24 60 43.94 109.91 99.86 99.91
120 20 50 24 60 43.96 109.84 99.90 99.85
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                            Table. 16: Statistical Validation of HIFEN-LXX 200 Tablet
Level  of 
% recover % Mean ± SD Standard error of mean
Cefixime Dicloxacillin Cefixime Dicloxacillin Cefixime Dicloxacillin
80 99.70 99.92 0.0624 0.0550 0.0625 0.0551
100 99.88 99.64 0.0529 0.0702 0.530 0.0704
120 99.91 99.84 0.0450 0.0650 0.0452 0.0651
Limit of detection (LOD):  LOD is calculated from 
the formula
LOD = 3.3σ/S
σ= Standard deviation of the response, s = slope of 
the calibration curve
Cefixime: 0.0831383 μg/mL
Dicloxacillin: 0.0610809 μg/mL
Limit  of  Quantitation  (LOQ):  LOQ  is  calculated 
from the formula
LOQ=10σ/S
σ= Standard deviation of the response S= slope of the 
calibration curve
Cefixime: 0.2519344 μg/mL
Dicloxacillin: 0.1850938 μg/mL
Linearity  Range:  The range  shown by is  given  as 
follows
 Cefixime: 10-100 μg/mL
 Dicloxacillin: 10-100 μg/mL
Robustness:  Robustness  of  the  method  was 
determined  by  carrying  out  the  analysis  under 
conditions during which mobile phase ratio and pH 
was altered. Variation of mobile phase pH and ratio 
are seemed to have greater impact on resolution and 
hence it should be meticulously controlled.
Analysis of tablet formulation:
After analysis of all the different brands of tablets the 
amount found is calculated which was within the limit 
of label claim. 
Fig. 24: Chromatogram of Cefixime (20 μg/mL) & 
Dicloxacillin (50 μg/mL tablet) in Tablet 
Formulation.
Table. 17: Analysis of  tablet
S. 
No.
Amount present in 
(µg)
Amount found in 
(µg) % Label claim
Cef. Diclo. Cef. Diclo. Cef. Diclo.
1 20 50 19.94 49.75 99.73 99.50
2 20 50 19.94 49.67 99.71 99.35
3 20 50 19.96 49.60 99.81 99.20
4 20 50 19.91 49.73 99.59 99.47
5 20 50 19.89 49.86 99.47 99.73
3. Result and Discussion
3.1 HPLC Method:
RP-HPLC  method  was  developed  and 
validated for estimation of Cefixime and Dicloxacillin 
from bulk drug and tablet formulation. Method was 
validated by using different parameters likes linearity, 
precision,  accuracy,  limit  of  detection,  limit  of 
quantitation, specificity, range and robustness.
Table 18: Optimized parameters for HPLC method
Parameters Chromatographic conditions
HPLC  System Cyberlab- Chrom-HPLC. V4.0
Pump LC-P-100 
Detector LC- UV 100 (UV Visible)
Column Capcell Pack  C-18 (4.6mm x 250 mm)
Column temperature Ambient
Mobile phase Methanol: phosphate buffer. (75:25).
Concentration of standard solution 100 μg/mL of Cefixime and 100 μg/mL of Dicloxacillin in mobile phase.
Detection of Wavelength 232 nm
Flow rate 1mL/min
Sample volume 10 µL
Run time 9.5 min
Retention time Cefixime: 3.19 min, Dicloxacillin: 6.68 min
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Method  of  RP  High  performance  liquid 
chromatography has been successfully employed for 
simultaneous  estimation  of  Cefixime  and 
Dicloxacillin  from  bulk  and  tablet  dosage  form. 
Method was validated as per ICH and USP guidelines 
by using different parameters like linearity, precision, 
accuracy,  limit  of  detection,  limit  of  quantitation, 
specificity,  range  and  robustness.  The  linearity  of 
Cefixime was observed in the range of 10-100 µg/mL 
and that of Dicloxacillin was in the range of 10-100 
µg/mL. Detection wavelength used was 232 nm with 
correlation  coefficient  0.9999  and  0.9994  for 
Cefixime and Dicloxacillin respectively. The limit of 
detection  was  found  to  be  0.0831383  µg/mL  and 
0.0610809  µg/mL  for  Cefixime  and  Dicloxacillin 
respectively & limit of quatitation 0.2519344 µg/mL 
and 0.1850938 µg/mL for Cefixime and Dicloxacillin 
respectively.  The percent relative standard deviation 
and high percent recovery data were satisfactory and 
confirms  accuracy,  precision  and  reliability  of  the 
method.  Thus  the  methods  are  simple,  accurate, 
precise,  economical  and  reproducible  for  routine 
estimation of Cefixime and Dicloxacillin respectively 
from bulk drug & formulations.
4. Conclusion
Conclusion  for  HPLC  Method:  Attempts  were 
made to develop RP-HPLC method for simultaneous 
estimation of Cefixime and Dicloxacillin from tablet 
formulation.   RP-HPLC  method  was  developd  and 
validated  as  per  ICH and USP guidelines  by using 
Methanol:  0.05M phosphate  buffer,  (75:25  v/v)  pH 
4.5 as mobile phase, Retention time of Cefixime and 
Dicloxacillin were found to be 3.19 min and 6.68 min 
respectively.  The wavelength used was 232 nm and 
flow rate was 1.0 mL/min. The method was found to 
be  simple,  accurate,  precise,  economical  and 
reproducible. So the propose method can be used for 
the routine quality control analysis of Cefixime and 
Dicloxacillin  in  bulk  drug  as  well  as  tablet 
formulations.
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